Biology is going fromscience to engineering.

Biological discovery used to be serendipitous, mistakes that turned into discoveries, like penicillin. Now we design new molecules with AI and test them in the lab, with the mission to close the biological loop autonomously.

Discovery has alwaysrun on human time.

For fifty years it has cost more and taken longer, because every result starts a new project instead of feeding the last one.

We’re closingthe biological loop.

Agents design candidate molecules. Our autonomous wet lab builds and tests them. Every result feeds straight back into the next design, and the loop runs again, faster and cheaper each time.

We’ve bent the curveof biological discovery.

What used to take five years now takes two. What took two now takes six months. We’re driving toward weeks.

Now, biological discovery stops resetting and starts compounding.

Our first discovery andflagship partnership arealready in play.

Our first molecule, AB‑01, blocks methane at the source and has held across multiple in‑vivo trials, at the lowest cost per gram methane reduction that anyone has reached.

A global partner deal is already signed and in development. This is not a pilot but a real go‑to‑market.

The largest players in the category have stopped waiting and started calling.

One methodology for everymarket biology touches.

Food production, a ten‑trillion‑dollar market with fast regulatory cycles, is where we chose to start. The methodology isn’t built for one problem. We’re driving toward full autonomy, and the next horizon: any biology problem, any vertical, solved the same way.

We’re just past the first horizon. What comes next is the rest of the sky.